HHS says it may be time to eliminate the complex system of drug rebates
U.S. Health and Human Services Secretary Alex Azar is calling for “a system without rebates.” HHS secretary Azar told lawmakers
Read More
Part D/Prescription Drugs
How America Got Hooked On A Deadly Drug
(By Fred Schulte for Kaiser Health News) Purdue Pharma left almost nothing to chance in its whirlwind marketing of its
Read MoreMedicare’s blueprint to tackle the opioid crisis
In 2016, more than 42,000 Americans died as a result of opioid use and of those, 40 percent involved a
Read MoreAntisense therapy
A new approach to killing C. difficile, the most common hospital-acquired bacterial infection in the US, is called antisense therapy.
Read MoreAs opioids legislation gains steam, efforts to address crisis collide with moneyed interests
(By Lev Facher for STAT) WASHINGTON — As legislation to address the opioid epidemic gains momentum, drug makers, insurers, and
Read MorePrice Check On Drug Ads: Would Revealing Costs Help Patients Control Spending?
(By Julie Appleby and Sydney Lupkin for Kaiser Health News) President Donald Trump wants to control spending on drugs. One
Read MoreA new cancer care dilemma: Patients want immunotherapy even when evidence is lacking
(By Casey Ross for STAT) Immunotherapy is a source of great hope in cancer care. It has rescued some patients from
Read MoreSeniors filled fewer prescriptions for brand-name drugs but spending is up
In a recent government report, Medicare recipients filled fewer prescriptions for pricey brand-name drugs but spent more on such meds
Read MoreMergers between health insurers and pharmacy benefit managers could be bad for your health
(By Barak Richman and Kevin Schulman for STAT) Pharmacy benefit managers, which long ran under the public radar, now have
Read More‘Right-to-try’ law intended to weaken the FDA, measure’s sponsor says in blunt remarks
(By Erin Mershon for STAT) WASHINGTON — Sen. Ron Johnson, the author of the federal “right-to-try” law signed by President Trump this
Read More